AGBL East Africa successfully installed the first five lasers spectrum flow cytometer in the African continent at the MRC/UVRI & LSHTM Uganda Research Unit, Entebbe in Uganda.

Dr. Stephen Cose, Lecturer in Immunology at London School of Hygiene & Tropical Medicine/ Uganda Research Unit, expressed his satisfaction, “The addition of a high end spectral analyzer technology to our benches will add a lot to our research capabilities, it means much more reach when it comes to the number biological markers and accuracy of detection, the AGBL team was instrumental in introducing us to this brilliant technology and their team of experts worked with us closely on all steps of this project, we are very thankful for their contribution”.

“We are proud to have completed the first five lasers spectrum flow cytometer in Africa, and very happy to this installation take place Uganda, we feel it will add great capabilities to our customer’s research, and we believe that this technology will become invaluable for many fields of research in Africa, especially immunology, with more and more researchers looking to upgrade their conventional flow cytometers to a spectral flow cytometry technology”, said Mr. Amrulah Hassen, Country Sales Manager at AGBL East Africa.

Please read the Press Release



About AGBL East Africa

AGBL East Africa is a member of the AGBL group of companies; the largest biomedical distribution group in the Middle East, Africa, and Asia region. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic centers in emerging healthcare markets. AGBL East Africa is headquartered in Nairobi, Kenya, and covers East Africa.



The MRC/UVRI & LSHTM Uganda Research Unit is an internationally recognized center of excellence for research on HIV infection and related diseases, contributing knowledge on the evolving epidemic, the evaluation of innovative health care options, treatment and prevention, and the development of health policy and practice in Africa and worldwide.